Telehealth platform used to remote examine and diagnose isolated patients

Telehealth platform Tyto Care is seeing its use being expanded to remotely examine and diagnose quarantined patients and isolated patients at home by its health partners in the U.S., Europe and Israel.  

As a result, it is providing health professionals the clinical data required to make treatment decisions from a safe distance and minimising physical contact to help stem the spread of COVID-19.

Using Tyto Care to remotely examine quarantined patients in hospitals and isolated patients at home, healthcare providers are able to avoid exposure and the “worried well” are able to receive care without entering medical facilities, preventing the spread of the virus and significantly reducing the increased burden on already overworked health organisations. 

Dedi Gilad, Tyto Care CEO and co-founder, said: “The fight against the COVID-19 pandemic is strengthening each day and as the virus continues to spread, we are focusing our efforts where we can make the most impact – easing the burden on healthcare providers serving quarantined and isolated patients. Tyto Care is uniquely suited to provide the remote exam and diagnostic capabilities required to aid affected populations at scale, fully realising telehealth’s potential during this crisis. It’s my hope that this pandemic passes quickly and that we can help flatten the curve.”